Torrent DO Brasil Limiteda Pharmaceutical Import Profile — Brazil (DGFT 2022–2026)

Name: Torrent DO Brasil Limiteda Pharmaceutical Import Records from India — 2 Products, $2.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Torrent DO Brasil Limiteda — Pharmaceutical Importer Profile (2026) | 2 Products, $2.2M Trade | TransData Nexus

Torrent DO Brasil Limiteda

Pharmaceutical Importer · Brazil · Advanced Diabetes Medications Focus · $2.2M Total Trade · DGFT Verified

Torrent DO Brasil Limiteda is a pharmaceutical importer based in Brazil with a total trade value of $2.2M across 2 products in 2 therapeutic categories. Based on 73 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Torrent DO Brasil Limiteda sources from 2 verified Indian suppliers, with Torrent Pharmaceuticals Limited accounting for 98.2% of imports.

Torrent DO Brasil Limiteda — Import Portfolio & Supplier Network

Torrent DO Brasil Limiteda import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Torrent DO Brasil Limiteda?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Torrent Pharmaceuticals Limited	$12.0M	458	98.2%
Aurobindo Pharma Limited	$219.7K	10	1.8%

Torrent DO Brasil Limiteda sources from 2 verified Indian suppliers across .

What Formulations Does Torrent DO Brasil Limiteda Import?

Formulation	Value	Ships
Other - rosucor 10 tablet	$350.0K	7
Venlift od 150 capsule(venlafaxine extended release 150MG)nos=3x10	$273.0K	6
Other - rosucor 10 MG tablets	$250.0K	5
Gliclazide mr 30MG tablets gliclazidemodified release 30 MG nos size 3 x	$212.4K	11
Other - rosucor 20 MG tablets	$200.0K	4
Other - indapen sr tablet indapamide	$195.1K	4
Olmecor 40 MG tablet olmesartan	$188.7K	4
Azukon mr tablet gliclazide modified	$165.8K	5
Other - rosuvastatin calcium 20MG tablet( rosuvastatin calcium 20MG ) nos size3x10	$157.2K	9
Other - venlift od 150 capsule venlafaxine extended release 150MG nos size 3x 10	$150.0K	3
Other - olmecor 40 MG tablet ( olmesartan medoxomil 40MG ) nos size 3x10	$150.0K	3
Other - rosuvastatin calcium 10MG	$140.5K	6
Other - venlafaxine ext rel 75MG capsules venlafaxine extended release capsules 75MG nos size 3 x 10	$140.1K	4
Gliclazide mr 30MG tablets	$131.4K	9
Torval cr 500 tablet ( sodium valproate333mg valproic acid 145MG) ) nos size 3x10	$131.3K	4

Torrent DO Brasil Limiteda imports 304 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Gliclazide	Advanced Diabetes Medications	$1.6M	58	0.5%	12
2	Bisoprolol	Cardiovascular	$576.7K	15	0.7%	19

Torrent DO Brasil Limiteda imports 2 pharmaceutical products across 2 categories into Brazil totaling $2.2M.

Torrent DO Brasil Limiteda — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Torrent do Brasil Limiteda is a Brazilian pharmaceutical company specializing in the importation and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Headquartered in São Paulo, Brazil, the company operates as a pharmaceutical buyer and importer, focusing on sourcing high-quality medications from international suppliers to meet the needs of the Brazilian market. While specific details about its parent company are not publicly disclosed, Torrent do Brasil Limiteda maintains a strategic partnership with Torrent Pharmaceuticals Limited, an Indian multinational pharmaceutical company. This collaboration enables Torrent do Brasil Limiteda to leverage Torrent Pharmaceuticals Limited's extensive product portfolio and manufacturing capabilities, enhancing its role in Brazil's pharmaceutical distribution network.

2Distribution Network

Torrent do Brasil Limiteda has established a robust distribution network to ensure efficient delivery of pharmaceutical products across Brazil. The company operates multiple warehouses strategically located in key regions, including São Paulo and Extrema, Minas Gerais. In May 2024, Torrent do Brasil inaugurated a new warehouse in Extrema, Minas Gerais, covering an area of 8,000 square meters. This facility aims to enhance operational efficiency, expedite product distribution, and implement sustainable practices. The São Paulo warehouse, located at Avenida Doutor Chucri Zaidan, 1240, Conjuntos 2401-2404, Vila São Francisco (Zona Sul), serves as the company's primary distribution hub. These strategically positioned warehouses enable Torrent do Brasil Limiteda to effectively serve the Brazilian market, ensuring timely and reliable delivery of pharmaceutical products nationwide.

3Industry Role

Torrent do Brasil Limiteda plays a pivotal role in Brazil's pharmaceutical supply chain as a pharmaceutical importer and distributor. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company ensures the availability of a diverse range of medications to meet the therapeutic needs of the Brazilian population. Its strategic partnerships with manufacturers like Torrent Pharmaceuticals Limited enable Torrent do Brasil Limiteda to offer high-quality products across various therapeutic categories, including cardiovascular, diabetes, and central nervous system disorders. Through its efficient distribution network and commitment to quality, Torrent do Brasil Limiteda contributes significantly to the accessibility and affordability of essential medications in Brazil.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Torrent DO Brasil Limiteda

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Torrent do Brasil Limiteda exhibits a high degree of sourcing concentration, primarily importing finished pharmaceutical formulations from two Indian suppliers: Torrent Pharmaceuticals Limited and Aurobindo Pharma Limited. The majority of imports, amounting to $12.0 million across 458 shipments (98.2% of total shipments), are sourced from Torrent Pharmaceuticals Limited. A smaller portion, $220,000 across 10 shipments (1.8% of total shipments), is sourced from Aurobindo Pharma Limited. This concentration indicates a strategic choice to maintain strong, long-term relationships with these suppliers, ensuring consistent product quality and supply reliability. However, such dependency also poses risks, including potential supply chain disruptions due to geopolitical issues, regulatory changes, or operational challenges faced by the suppliers. To mitigate these risks, Torrent do Brasil Limiteda may consider diversifying its supplier base and establishing contingency plans to maintain a resilient supply chain.

2Supply Chain Resilience

The resilience of Torrent do Brasil Limiteda's supply chain is closely tied to its reliance on a limited number of suppliers. While the strong partnership with Torrent Pharmaceuticals Limited ensures a steady supply of high-quality products, the limited supplier base may expose the company to risks such as supply disruptions or price volatility. The company imports a diverse range of 304 unique formulations, indicating a broad product portfolio that can cater to various therapeutic needs. To enhance supply chain resilience, Torrent do Brasil Limiteda could explore establishing relationships with additional suppliers, both within and outside India, to reduce dependency and increase flexibility. Additionally, implementing robust inventory management practices and maintaining strategic stock levels can help mitigate potential supply chain disruptions.

Importing Pharmaceuticals into Brazil — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Brazil

1Regulatory Authority & Framework

In Brazil, the primary regulatory authority overseeing the pharmaceutical industry is the National Health Surveillance Agency (ANVISA). ANVISA is responsible for regulating and supervising the production, commercialization, and distribution of pharmaceutical products to ensure public health safety. Key legislation governing pharmaceutical imports includes Law 9.782/1999, which establishes the National Health Surveillance System, and Law 6.360/1976, which regulates the sanitary control of the production and commercialization of pharmaceutical products. The marketing authorization pathway for Indian generics involves obtaining pre-market approval from ANVISA, which requires a partner company legally established in Brazil to assume legal responsibility for the products imported and distributed within the country. This partner company must ensure compliance with ANVISA's regulatory requirements, including product registration, quality standards, and post-marketing surveillance.

2Import Licensing & GMP

Import licensing requirements in Brazil stipulate that foreign companies must designate a legally established partner in Brazil to handle the importation and distribution of pharmaceutical products. This partner company is responsible for obtaining the necessary import licenses and ensuring compliance with ANVISA's regulations. Good Manufacturing Practices (GMP) certification is a critical component of the import process. ANVISA aligns its GMP guidelines with the Pharmaceutical Inspection Co-operation Scheme (PIC/S), adopting internationally recognized standards to ensure the quality and consistency of pharmaceutical products. The main regulation applicable to GMP is RDC 658/2022, which outlines the general GMP guidelines for medicines. Additionally, the partner company must hold a wholesale distribution authorization to legally distribute pharmaceutical products within Brazil.

Torrent DO Brasil Limiteda — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Torrent do Brasil Limiteda's product strategy focuses on importing finished pharmaceutical formulations in the therapeutic areas of cardiovascular and diabetes, central nervous system disorders, and generics. This strategic focus aligns with the growing demand for treatments in these areas within the Brazilian market. The company's emphasis on high-quality products at affordable prices addresses the needs of a diverse patient population, including those in underserved regions. By concentrating on these therapeutic categories, Torrent do Brasil Limiteda aims to enhance the quality of life for Brazilian patients and strengthen its position in the competitive pharmaceutical market.

2Sourcing Profile

Torrent do Brasil Limiteda's sourcing strategy centers on importing generic drugs from India, leveraging the country's established reputation for producing high-quality, cost-effective pharmaceutical products. The company imports a diverse range of 304 unique formulations, indicating a broad product portfolio that can cater to various therapeutic needs. This approach allows Torrent do Brasil Limiteda to offer a wide array of medications to the Brazilian market, ensuring access to essential treatments across multiple therapeutic areas. By sourcing from India, the company benefits from competitive pricing and a reliable supply chain, contributing to the affordability and availability of medications in Brazil.

Market Positioning

Seller's Guide — How to Become a Supplier to Torrent DO Brasil Limiteda

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Torrent do Brasil Limiteda, especially if they can offer competitive pricing, high-quality products, and reliable supply capabilities. The company's current sourcing pattern, with a high concentration

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Torrent DO Brasil Limiteda

What products does Torrent DO Brasil Limiteda import from India?

Torrent DO Brasil Limiteda imports 2 pharmaceutical products across 2 categories. Top imports: Gliclazide ($1.6M), Bisoprolol ($576.7K).

Who supplies pharmaceuticals to Torrent DO Brasil Limiteda from India?

Torrent DO Brasil Limiteda sources from 2 verified Indian suppliers. The primary supplier is Torrent Pharmaceuticals Limited (98.2% of imports, $12.0M).

What is Torrent DO Brasil Limiteda's total pharmaceutical import value?

Torrent DO Brasil Limiteda's total pharmaceutical import value from India is $2.2M, based on 73 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Torrent DO Brasil Limiteda focus on?

Torrent DO Brasil Limiteda imports across 2 categories. The largest: Advanced Diabetes Medications (73.7%), Cardiovascular (26.3%).

Get Full Torrent DO Brasil Limiteda Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.